期刊文献+

冒烟型骨髓瘤的研究进展

Progress in smoldering multiple myeloma
原文传递
导出
摘要 第21届欧洲血液学会年会在多发性骨髓瘤的基础研究、疾病诊治方面都取得了令人振奋的进展.年会上特别将冒烟型骨髓瘤作为一个专题来讲解,从其定义到进展的高危因素以及当前对冒烟型骨髓瘤理念的转变作了详细的阐述. Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder.There have been many advances in the diagnosis,prognosis and management of multiple myeloma at the 21th European Hematology Association Annual Meeting,especially SMM being discussed as a topic.These include a revised disease definition,new prognostic factors and new treatment options.
作者 钟玉萍
出处 《白血病.淋巴瘤》 CAS 2016年第8期454-456,460,共4页 Journal of Leukemia & Lymphoma
关键词 冒烟型骨髓瘤 高危因素 治疗 Smoldering multiple myeloma Risk factors Treatment
  • 相关文献

参考文献24

  • 1Kyle RA, Greipp PR. Smoldering multiple myeloma [J]. N Engl J Med, 1980, 302(24): 1347-1349.
  • 2Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma [J]. Lancet Oncol, 2014, 15 (12): e538-e548.
  • 3L6pez-Corral L, Sarasquete ME, Be S, et al. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status[J]. Leukemia, 2012, 26( 12): 2521-2529.
  • 4Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma [J]. Nat Rev Cancer, 2012,12,12 (5) : 335-348.
  • 5Dosani T, Carlsten M, Maric I, et al. The cellular immune system inmyelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies [J]. Blood Cancer J, 2015, 5: e321.
  • 6Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma [J]. Lancet Oncol, 2014, 15 (12):e538-e548.
  • 7Rajkumar SV, Larson D, Kyle RA. Diagnosis of smoldering muhiple myeloma [J]. N Engl J Med, 2011, 365 (5): 474-475.
  • 8Kastritis E, Terpos E, Moulopoulos L, et al. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease [J]. Leukemia, 2013, 27 (4): 947-953.
  • 9Rago A, Grammatico S, Za T, et al. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form [ J ]. Cancer, 2012, 118(22) : 5544-5549.
  • 10Dispenzieri A, Kyle RA, Katzmann JA, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma[J]. Blood, 2008, 111 (2) : 785-789.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部